Invited Speaker

Clare Slaney, PhD

Senior Research Fellow
Peter MacCallum Cancer Centre, Australia

Dr. Slaney’s current research interests are in understanding the interaction between the immune system and cancer, and in the use of immunotherapy to treat cancer. These interests include the use of genetically modified T cells (CAR T cells) to treat solid cancers. Dr. Slaney has published over 40 papers in high-impact journals including first and last authorships in Nature Medicine, PNAS, Cancer Research, Clinical Cancer Research and Cancer Discovery. She has obtained over $13 million research funding, including 3 fellowships, 6 CIA project grants and a startup grant to form a spinout company Currus Biologics to develop novel CAR T cell therapies. Her accomplishments have been acknowledged with a number of awards including the Seymour and Vivian Milstein Young Investigator Award for notable contributions to basic and clinical research in Switzerland (2012), a Joseph Sambrook Award in Research Excellence (2014), and the respected Mavis Robertson Award (2018) that is given each year to a female principal investigator considered to exhibit the greatest promise as a leader in breast cancer research in Australia.

Selected Publications

Chan JD, et al. Nat Rev Immunol.2021 
Tantalo DG, et al. J Immunother Cancer. 2021 
Ali AI, et al. Clin Cancer Res. 2021 
Scheidt B, et al, PNAS, 2019 
Slaney CY, et al, Cancer Discov, 2018 
Beavis PA et al, JCI, 2017 
Slaney CY, et al. Clin Cancer Res. 2017 
Bidwell BN, et al. Nature Med. 2012